Russian biologists from the Federal Medical-Biological Agency (FMBA) have developed a monkeypox vaccine, Interfax reports quoting FMBA chief Veronika Skvortsova.
According to Skvortsova, the viral vector vaccine is currently going through the preclinical research phase. This vaccine is safe, with no side effects, unlike the previous smallpox jabs, she noted.
The expert also spoke about another innovation, an allergy vaccine, which is now undergoing clinical trials.
The first monkeypox case in Russia was reported in July, when the rare infection was found in a tourist who had returned from Portugal. Although it is most common in Africa, more than 50,000 cases have been reported around the world by now.